关于先锋

Company Profile

Pioneer Information

Notice Announcement

Industry News

Environmental information disclosure

Shaanxi

Release time:

2019-06-27

Drug Name Specifications Conversion factor
Fenofibrate Capsules 0.2g 10
Lysine for Injection 0.9g 1
Anetellithin Tablets 25mg 12
Guipi Capsule 0.3g 36
Guipi Capsule 0.3g 48
Clindamycin Phosphate for Injection 0.6g (according to clindamycin) 1
Clindamycin hydrochloride for injection 0.3g 1
Clindamycin hydrochloride for injection 0.6g 1
Clindamycin Phosphate for Injection 0.3g (according to clindamycin) 1
Diammonium glycyrrhizinate enteric-coated tablets 50mg 24
Cefoxitin Sodium for Injection 1.0g 1
Clindamycin hydrochloride for injection 0.15g 1
Sodium creatine phosphate for injection 1.0g 1
Sodium creatine phosphate for injection 0.5g 1
Ambroxol Hydrochloride Capsules 30mg 24
Ambroxol Hydrochloride Capsules 60mg 24
Ambroxol Hydrochloride Capsules 60mg 12
Azithromycin for Injection 0.5g 1
Back →

Related news

2023-03-08

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

2023-02-27

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

2023-02-25

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs